Clinical Trial Update: Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant single-chain Factor VIII (rVIII-SingleChain) in Chinese participants with congenital Hemophilia A who were previously treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rVIII-SingleChain (Factor VIII, recombinant, single-chain)

Snippet

Sponsor: CSL Behring | Conditions: Congenital Hemophilia A | Phase 3 | Status: ACTIVE_NOT_RECRUITING